Walleye Capital’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-11,300
Closed -$58.5K 5005
2025
Q3
$58.5K Sell
11,300
-5,600
-33% -$32.2K ﹤0.01% 3952
2025
Q2
$100K Buy
+16,900
New +$102K ﹤0.01% 3770
2025
Q1
Sell
-19,500
Closed -$161K 4960
2024
Q4
$161K Buy
19,500
+10,300
+112% +$82.6K ﹤0.01% 3889
2024
Q3
$70.4K Sell
9,200
-6,500
-41% -$59.9K ﹤0.01% 4532
2024
Q2
$163K Sell
15,700
-7,500
-32% -$82.2K ﹤0.01% 4445
2024
Q1
$277K Buy
+23,200
New +$258K ﹤0.01% 3720
2023
Q4
Sell
-300
Closed -$4.15K 5399
2023
Q3
$4.15K Buy
+300
New +$4.39K ﹤0.01% 4617
2019
Q4
Sell
-18,100
Closed -$155K 2178
2019
Q3
$155K Buy
18,100
+3,100
+21% +$30.4K 0.01% 1292
2019
Q2
$173K Buy
+15,000
New +$193K 0.02% 1024

Other funds holding PTEN

Walleye Capital's PTEN Position: Q1 2026 in Review

Walleye Capital opened a new position in Patterson-UTI (PTEN) in Q1 2026: 312,266 shares worth $3.38M. The stake represents 0.01% of the portfolio and ranks #1056 among its holdings. This is a return to the name: Walleye Capital previously reported a position in PTEN as recently as Q3 2025.

Walleye Capital first reported a position in PTEN in Q2 2020 and has held it in 12 quarters since. The position peaked at $13.3M in Q3 2023. 410 funds tracked by Wall St. Rank hold PTEN as of Q1 2026.

  • Walleye Capital held 312,266 shares of Patterson-UTI worth $3.38M as of Q1 2026.
  • Patterson-UTI was a new Walleye Capital position in Q1 2026.
  • Patterson-UTI made up 0.01% of Walleye Capital's portfolio in Q1 2026, its #1056 holding.
  • Walleye Capital first reported a position in Patterson-UTI in Q2 2020 and has held it in 12 quarters since.
  • Walleye Capital's Patterson-UTI position peaked at $13.3M in Q3 2023.
  • 410 funds tracked by Wall St. Rank held Patterson-UTI as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.